Abstract
With a dual-labeled imaging agent, Optical/CT/PET primary prostate cancer imaging was performed in a Siemens Inveon scanner. PET-based imaging validation shows the potential of the developed fluorescence tomography for preclinical research.
© 2012 Optical Society of America
PDF ArticleMore Like This
Chinmay Darne, Yujie Lu, I-Chih Tan, and Eva M. Sevick-Muraca
BTu3A.70 Biomedical Optics (BIOMED) 2012
Changqing Li, Julien Bec, and Simon R. Cherry
BMB6 Biomedical Optics (BIOMED) 2010
Tracy W. Liu, Thomas D. MacDonald, Cheng Jin, Brian C. Wilson, and Gang Zheng
BSu3A.14 Biomedical Optics (BIOMED) 2012